Arrow-right Camera
The Spokesman-Review Newspaper
Spokane, Washington  Est. May 19, 1883

EndNotes

Sign of Scorpio

A scorpion uses the venomous stinger at the end of its tail primarily to subdue insect prey.
A scorpion uses the venomous stinger at the end of its tail primarily to subdue insect prey.

The FDA has approved the use of scorpion-derived venom in human trials on brain cancer patients.

Really.

The re-engineered protein from the scorpion is mixed with a fluorescent molecule "flashlight;" the product, called “tumor paint,” illuminates tumors or areas so small a physician may be unable to detect them.  It is the scorpion protein that binds to the cancer cells.

The first trial will be used on estimated 21 people with a glioma, or tumor in the brain or spine.

(S-R photo: A scorpion)



Spokesman-Review features writer Rebecca Nappi, along with writer Catherine Johnston of Olympia, Wash., discuss here issues facing aging boomers, seniors and those experiencing serious illness, dying, death and other forms of loss.